Dashboard
Manage Tickers

PTCT


   

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

ptc-therapeutics-could-challenge-biomarin-for-metabolic-disorder-treatment
PTC Therapeutics Could Challenge BioMarin ...
09/08/2025 17:56:24

BioMarin's Palynziq significantly lowered blood phenylalanine in teens with PKU, with nearly half reaching target levels in...

cantor-fitzgerald-reiterates-overweight-on-ptc-therapeutics-maintains-118-price-target
Cantor Fitzgerald Reiterates Overweight on...
09/03/2025 13:49:29

Cantor Fitzgerald analyst Kristen Kluska reiterates PTC Therapeutics (NASDAQ:PTCT) with a Overweight and maintains $118 pric...

ptc-therapeutics-stock-is-stuck-in-a-multi-year-slump
PTC Therapeutics Stock Is Stuck In A Multi...
08/21/2025 14:00:45

PTC Therapeutics is stuck with uncertainty stretching through 2030. Here's why the stock remains a long-term avoid.

wells-fargo-maintains-overweight-on-ptc-therapeutics-lowers-price-target-to-73
Wells Fargo Maintains Overweight on PTC Th...
08/20/2025 18:42:36

Wells Fargo analyst Tiago Fauth maintains PTC Therapeutics (NASDAQ:PTCT) with a Overweight and lowers the price target from ...

morgan-stanley-maintains-overweight-on-ptc-therapeutics-lowers-price-target-to-71
Morgan Stanley Maintains Overweight on PTC...
08/20/2025 15:53:58

Morgan Stanley analyst Jeffrey Hung maintains PTC Therapeutics (NASDAQ:PTCT) with a Overweight and lowers the price target f...

b-of-a-securities-maintains-buy-on-ptc-therapeutics-lowers-price-target-to-76
B of A Securities Maintains Buy on PTC The...
08/20/2025 12:21:22

B of A Securities analyst Tazeen Ahmad maintains PTC Therapeutics (NASDAQ:PTCT) with a Buy and lowers the price target from ...

ptc-therapeutics-faces-fda-rejection-on-rare-disease-treatment-over-efficacy-concerns
PTC Therapeutics Faces FDA Rejection On Ra...
08/19/2025 15:20:22

FDA rejected PTC Therapeutics' vatiquinone for Friedreich's ataxia, citing insufficient efficacy data and requiring ano...

trading-halt-halt-status-updated-at-82500-am-et-quotation-resumption-news-and-resumption-times
Trading Halt: Halt status updated at 8:25:...
08/19/2025 12:25:16

ptc-therapeutics-receives-complete-response-letter-from-the-fda-regarding-its-nda-for-vatiquinone
PTC Therapeutics Receives Complete Respons...
08/19/2025 12:03:56

trading-halt-halted-at-75500-am-et---trading-halt-halt-news-pending
Trading Halt: Halted at 7:55:00 a.m. ET - ...
08/19/2025 11:55:04

rbc-capital-maintains-outperform-on-ptc-therapeutics-raises-price-target-to-63
RBC Capital Maintains Outperform on PTC Th...
08/08/2025 18:29:10

RBC Capital analyst Brian Abrahams maintains PTC Therapeutics (NASDAQ:PTCT) with a Outperform and raises the price target fr...

wells-fargo-maintains-overweight-on-ptc-therapeutics-raises-price-target-to-79
Wells Fargo Maintains Overweight on PTC Th...
08/08/2025 15:26:13

Wells Fargo analyst Tiago Fauth maintains PTC Therapeutics (NASDAQ:PTCT) with a Overweight and raises the price target from ...

ptc-therapeutics-affirms-fy2025-sales-guidance-of-65000m-80000m-vs-175b-est
PTC Therapeutics Affirms FY2025 Sales Guid...
08/07/2025 20:02:35

PTC Therapeutics (NASDAQ:PTCT) affirms FY2025 sales outlook from $650.00 million-$800.00 million to $650.00 million-$800.00 mil...

ptc-therapeutics-q2-eps-083-beats-098-estimate-sales-17888m-beat-17146m-estimate
PTC Therapeutics Q2 EPS $(0.83) Beats $(0....
08/07/2025 20:02:05

PTC Therapeutics (NASDAQ:PTCT) reported quarterly losses of $(0.83) per share which beat the analyst consensus estimate of $(0....

Core News & Articles
Earnings Scheduled For August 7, 2025
08/07/2025 08:33:15

ptc-therapeutics-earnings-preview
PTC Therapeutics Earnings Preview
08/06/2025 17:02:22

sephience-gets-fda-approval-now-a-key-revenue-driver-for-ptc-therapeutics
Sephience Gets FDA Approval, Now A Key Rev...
07/29/2025 17:58:58

PTC Therapeutics secures FDA approval for Sephience in PKU, launching August with analysts projecting strong revenue and broad ...

truist-securities-maintains-buy-on-ptc-therapeutics-raises-price-target-to-86
Truist Securities Maintains Buy on PTC The...
07/29/2025 15:54:13

Truist Securities analyst Joon Lee maintains PTC Therapeutics (NASDAQ:PTCT) with a Buy and raises the price target from $80 ...

these-analysts-increase-their-forecasts-on-ptc-therapeutics
These Analysts Increase Their Forecasts On...
07/29/2025 15:23:21

b-of-a-securities-maintains-buy-on-ptc-therapeutics-raises-price-target-to-84
B of A Securities Maintains Buy on PTC The...
07/29/2025 15:23:02

B of A Securities analyst Tazeen Ahmad maintains PTC Therapeutics (NASDAQ:PTCT) with a Buy and raises the price target from ...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION